NGNE
Neurogene Inc. - Common Stock (NGNE)
$09
About Neurogene Inc. - Common Stock (NGNE)
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Details
Daily high
$33.15
Daily low
$31.86
Price at open
$32.49
52 Week High
$43.66
52 Week Low
$15.93
Market cap
642.2M
Dividend yield
-
Volume
1.4M
Avg. volume
278,424
P/E ratio
-5.83
Neurogene Inc. - Common Stock News
Details
Daily high
$33.15
Daily low
$31.86
Price at open
$32.49
52 Week High
$43.66
52 Week Low
$15.93
Market cap
642.2M
Dividend yield
-
Volume
1.4M
Avg. volume
278,424
P/E ratio
-5.83